Skip to main content
PMC home page
American Journal of Alzheimer's Disease and Other Dementias logoLink to American Journal of Alzheimer's Disease and Other Dementias
. 2008 Dec;23(6):516–527. doi: 10.1177/1533317508328194

100 Years After Alzheimer: Contemporary Neurology Practice Assessment of Referrals for Dementia

Tiffany W Chow 1, Carin Binder 2, Steven Smyth 3, Sharon Cohen 4, Alain Robillard 5
PMCID: PMC10846208  PMID: 19106275

Abstract

Background: The prevalence of dementia is placing an increased burden on specialists.

Methods: Canadian neurologists responded to a structured questionnaire to assess reasons for referral and services provided as well as to compare the neurologists' perceptions of their practice characteristics against cases seen over a 3-month period.

Results: The audit confirmed the participants' perception that family practitioners are the main referral source (358/453, 79%). Sixty-two percent of patients had undergone clinical investigation for dementia prior to being seen by the neurologist; 39% (177/453) were on pharmacotherapy at the time of referral, 68% were initiated on pharmacotherapy by the neurologist. A fifth of the referrals did not meet clinical criteria for dementia, which may be directly related to the prevalence of prior workup that did not include mental status testing.

Conclusions: Neurologists currently treat patients referred for dementia who may already have been adequately evaluated and treated by primary care providers.

Keywords: Alzheimer's disease, dementia, specialist, referral and consultation, physician's practice patterns

Full Text

The Full Text of this article is available as a PDF (141.9 KB).

Contributor Information

Tiffany W. Chow, Department of Medicine, Division of Neurology, University of Toronto, Department of Psychiatry, Division of Geriatric Psychiatry, University of Toronto, Baycrest Division of Neurology and Rotman Research Institute.

Carin Binder, Janssen-Ortho, Inc, cbinder@its.jnj.com .

Steven Smyth, Janssen-Ortho, Inc.

Sharon Cohen, Department of Medicine, Division of Neurology, University of Toronto, Toronto Memory Program Toronto, Ontario.

Alain Robillard, Hopital Maisonneuve Rosemont and University de Montreal Dept of Neurology, Montreal, Quebec Canada.

References

  1. Lindsay J., Sykes E., McDowell I., et al. More than the epidemiology of Alzheimer's disease: contributions of the Canadian Study of Health and Aging. Can J Psychiatr . 2004;49:83-91. [DOI] [PubMed] [Google Scholar]
  2. Herbert Liesi E., Scherr Paul A., Bienias Julia L., Bennett David A., Evans Denis A. Alzheimer disease in the US population. Prevalence estimates using the 2000 Census. Arch Neurol. 2003;60:1119-1122. [DOI] [PubMed] [Google Scholar]
  3. Ostbye T., Crosse E. Net economic costs of dementia in Canada. Can Med Assoc J . 1994;151:2457-1464. [PMC free article] [PubMed] [Google Scholar]
  4. Schubert CC, Boustani M., Callahan CM, et al. Comorbidity profile of dementia patients in primary care: are they sicker? J Am Geriatr Soc. 2006;54:104-109. [DOI] [PubMed] [Google Scholar]
  5. Gill SS, Mamdani M., Naglie G., et al. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med. 2005. ;165:808-813. [DOI] [PubMed] [Google Scholar]
  6. Bergman-Evans B. Evidence-based guideline. Improving medication management for older adult clients . J Gerontol Nurs. 2006;32:6-14. [DOI] [PubMed] [Google Scholar]
  7. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1143-1153. [DOI] [PubMed] [Google Scholar]
  8. Petersen RC, Stevens JC, Ganguli M., Tangalos EG, Cummings JL, DeKosky ST Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1133-1142. [DOI] [PubMed] [Google Scholar]
  9. Cody M., Beck C., Shue VM, Pope S. Reported practices of PCPs in the diagnosis and management of dementia. Aging Ment Health. 2002;1:72-76. [DOI] [PubMed] [Google Scholar]
  10. Gauthier S., Feldman H., Keran R., et al. Sooner versus later: which dementia symptoms and co-morbid conditions initiate physician contact? Presented as a poster at the International Society of Vascular, Behavioral and Cognitive Disorders. San Antonio, Texas, July 11-15, 2007. [Google Scholar]
  11. Forette F., Seux ML, Staessen JA, et al. Prevention of dementia in randomized double-blind placebo controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:1347-1351. [DOI] [PubMed] [Google Scholar]
  12. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041. [DOI] [PubMed] [Google Scholar]
  13. Rockwood K. , MacKnight C., Wentzel C., et al. for the CIVIC Investigators. The diagnosis of ``Mixed'' dementia in the consortium for the investigation of vascular impairment of cognition (CIVIC). Ann N Y Acad Sci. 2000;903:522-528. [DOI] [PubMed] [Google Scholar]
  14. Shepherd J. , Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet. 2002;360: 1623-1630. [DOI] [PubMed] [Google Scholar]
  15. Hansson L., Lithel H., Skoog I., et al. Study on Cognition and Prognosis in the Elderly (SCOPE): baseline characteristics. Blood Press. 2000;9:146-151. [PubMed] [Google Scholar]
  16. Waldemar G. , Dubois B., Emre M., et al. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol. 2007. ;14:e1-e26. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Alzheimer's Disease and Other Dementias are provided here courtesy of SAGE Publications

RESOURCES